During our CY 2026 OPPS/ASC proposed rule assessment of CPT code X432T, we determined that the enhanced lithotripsy service involved a non-FDA approved device not excepted by any IDE status and therefore not payable under the OPPS/ASC because non-FDA approved devices are considered not reasonable and necessary under Section 1862(a)(1)(A) of the Act
Targets Visceral Fat and Trunk Adiposity Tesofensine appears particularly effective at reducing deep belly fat the type of fat that resists traditional diet/cardio and blunts vascularity and definition
Consistent weekly injections for at least 4-6 weeks allow adequate time to assess meaningful response
Optimal Administration Timing: Morning injection: 6-8 AM, before breakfast Fasted state: 30-60 minutes before first meal Consistent daily timing: Same time each day for stable blood levels Avoid evening administration: May interfere with sleep in sensitive individuals Cycling Protocols: Proper cycling prevents potential tolerance development and allows natural NNMT function to reset between treatment periods: Standard Cycle: 8 weeks on treatment 4 weeks off treatment Suitable for most users seeking metabolic enhancement Extended Cycle: 12 weeks on treatment 6 weeks off treatment For individuals with significant metabolic goals Requires careful monitoring throughout cycle Conservative Cycle: 6 weeks on treatment 3 weeks off treatment Ideal for first-time users or those with sensitivity concerns During off-cycle periods, focus on maintaining healthy lifestyle habits established during treatment
Standard Reconstitution Examples (Targeting 1050 Units) 250 mcg (0.25 mg) dose in a 10 mg vial: Add 1 mL BAC water = 25 units (0.25 mL draw)
International orders may face delays, import duties, or seizure risks depending on origin country and declaration accuracy
